Literature DB >> 27722749

Primary Tumor Sidedness as Prognostic and Predictive Biomarker in Metastatic Colorectal Cancer: Further Validation of a Potentially Practice-Changing Variable.

Kristen K Ciombor1, Richard M Goldberg1.   

Abstract

Entities:  

Year:  2017        PMID： 27722749     DOI： 10.1001/jamaoncol.2016.3777

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  8 in total

1.  Prognostic significance of primary tumor sidedness in patients undergoing liver resection for metastatic colorectal cancer.

Authors:  Emily K Elizabeth McCracken; Gregory P Samsa; Deborah A Fisher; Norma E Farrow; Karenia Landa; Kevin N Shah; Dan G Blazer; Sabino Zani
Journal:  HPB (Oxford)       Date:  2019-05-30       Impact factor: 3.647

2.  The side of the primary tumor affects overall survival in colon adenocarcinoma: an analysis of the national cancer database.

Authors:  M C Turner; D Becerra; Z Sun; J Watson; K Leung; J Migaly; C R Mantyh; D G Blazer
Journal:  Tech Coloproctol       Date:  2019-06-12       Impact factor: 3.781

3.  A retrospective observational study to estimate the attrition of patients across lines of systemic treatment for metastatic colorectal cancer in Canada.

Authors:  H Kennecke; S Berry; J Maroun; P Kavan; N Aucoin; F Couture; M Poulin-Costello; B Gillesby
Journal:  Curr Oncol       Date:  2019-12-01       Impact factor: 3.677

4.  Another Chapter of the Right Versus Left Story: Is Primary Tumor Location a Prognostic Feature in RAS Mutant Metastatic Colorectal Cancer?

Authors:  Fotios Loupakis; Marta Schirripa; Rossana Intini; Francesca Bergamo; Roberta Bertorelle; Matteo Fassan; Vincenzo Dadduzio; Stefano Merigliano; Pierluigi Pilati; Emanuele Luca Damiano Urso; Umberto Cillo; Massimo Rugge; Sara Lonardi; Vittorina Zagonel
Journal:  Oncologist       Date:  2018-08-17

Review 5.  BRAF Mutations as Predictive Biomarker for Response to Anti-EGFR Monoclonal Antibodies.

Authors:  Emilie M J van Brummelen; Anthonius de Boer; Jos H Beijnen; Jan H M Schellens
Journal:  Oncologist       Date:  2017-06-02

Review 6.  Recent Advances in Targeting the EGFR Signaling Pathway for the Treatment of Metastatic Colorectal Cancer.

Authors:  Yuji Miyamoto; Koichi Suyama; Hideo Baba
Journal:  Int J Mol Sci       Date:  2017-04-02       Impact factor: 5.923

7.  Chemotherapy plus bevacizumab as an optimal first-line therapeutic treatment for patients with right-sided metastatic colon cancer: a meta-analysis of first-line clinical trials.

Authors:  Xia-Hong You; Yu-Huan Jiang; Zhou Fang; Fan Sun; Yao Li; Wei Wang; Zi-Jin Xia; Xiao-Zhong Wang; Hou-Qun Ying
Journal:  ESMO Open       Date:  2020-03

8.  Primary Tumor Location and Outcomes After Cytoreductive Surgery and Intraperitoneal Chemotherapy for Peritoneal Metastases of Colorectal Origin.

Authors:  Mohammad Adileh; Jonathan B Yuval; Henry S Walch; Walid K Chatila; Rona Yaeger; Julio Garcia-Aguilar; Nikolaus Schultz; Philip B Paty; Andrea Cercek; Garrett M Nash
Journal:  Ann Surg Oncol       Date:  2020-08-25       Impact factor: 5.344
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.